Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies.
Jing Zhang,Baian Chen,Jing Lu,Yi Wu,Shubo Wang,Zitong Yao,Liming Zhu,Yanhua Qiao,Quan Sun,Wei Qin,Qiao Zhao,Jianping Jia,Cuibai Wei
DOI: https://doi.org/10.1111/acel.12978
IF: 11.005
2019-01-01
Aging Cell
Abstract:Cerebral amyloid beta (A beta) deposits are the main early pathology of Alzheimer's disease (AD). However, abundant A beta deposits also occur spontaneously in the brains of many healthy people who are free of AD with advancing aging. A crucial unanswered question in AD prevention is why AD does not develop in some elderly people, despite the presence of A beta deposits. The answer may lie in the composition of A beta oligomer isoforms in the A beta deposits of healthy brains, which are different from AD brains. However, which A beta oligomer triggers the transformation from aging to AD pathogenesis is still under debate. Some researchers insist that the A beta 12-mer causes AD pathology, while others suggest that the A beta dimer is the crucial molecule in AD pathology. Aged rhesus monkeys spontaneously develop A beta deposits in the brain with striking similarities to those of aged humans. Thus, rhesus monkeys are an ideal natural model to study the composition of A beta oligomer isoforms and their downstream effects on AD pathology. In this study, we found that A beta deposits in aged monkey brains included 3-mer, 5-mer, 9-mer, 10-mer, and 12-mer oligomers, but not 2-mer oligomers. The A beta deposits, which were devoid of A beta dimers, induced glial pathology (microgliosis, abnormal microglia morphology, and astrocytosis), but not the subsequent downstream pathologies of AD, including Tau pathology, neurodegeneration, and synapse loss. Our results indicate that the A beta dimer plays an important role in AD pathogenesis. Thus, targeting the A beta dimer is a promising strategy for preventing AD.